Cervical cancer Trials in Wuhan, China
Conditions / Cervical cancer / Wuhan, China
Cervical cancer has been the subject of sustained clinical investigation across multiple research sites.
38 total trials for this combination
Showing top 10 of 38 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04697628 | Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | COMPLETED | PHASE3 |
| NCT06846099 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 | COMPLETED | PHASE1 |
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | UNKNOWN | — |
| NCT06036121 | A Study of ADRX-0706 in Select Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT04152499 | Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06459180 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) | RECRUITING | — |
| NCT06459180 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) | RECRUITING | — |
| NCT06535607 | Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT01267851 | Clinical Database and Biobank of Patients With Gynecologic Neoplasms | UNKNOWN | — |